Nachrichten zur Pfizer Inc. Aktie

Pfizer director Daniel Cronin sells shares worth $20,140 By Investing.com

Pfizer director Daniel Cronin sells shares worth $20,140…

NYC Project to Convert Former Pfizer Headquarters Lands $135 Million Loan

The effort to convert Pfizer Inc.’s former New York headquarters into residences secured financing to help developers forge ahead on…

Pfizer Aktie: Negatives Sentiment für den Pharmasektor in 2025

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse der Citigroup: 1. Kurszielsenkung und Begründung Analyst Geoff Meacham hat das Kursziel für die Aktie von Pfizer…

Market Panic Over DeepSeek? Why Nvidias $500 Billion Drop Is Pure Hysteria.

Yesterday, a piece of breaking news sent technology stocks into a tailspin. The Chinese start-up DeepSeek developed an AI chatbot…

I Own 4 High-Yield Dividend Stocks. Heres Why I Own Each One.

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to the S&P 500 over holding periods…

This Chinese MIT Physicist Uses AI To Find New Drugs. Next Up: Solar Panels And EV Batteries

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to…

PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor

A Bloomberg article suggests activist investor Starboard cut Pfizer some slack by not nominating any director on the companys board…

Have $500? 2 High-Yield Dividend Stocks to Buy Right Now

Dividend stocks can be a great way to boost your portfolios growth potential or provide a form of passive income…

Pfizer succeeds in late-stage trial for colorectal cancer therapy

…

Got $100? This Top Dividend ETF Is a No-Brainer Buy Right Now.

Dividend stocks make great long-term investments. For example, an investor who bought $100 worth of average dividend stocks in 1973…

Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.

Some stocks pay juicy dividends for a while only for the income to later dwindle. Others generate consistent and reliable…

Pfizer to pay $59.7 million over kickbacks for migraine drug

…

Pfizer Aktie: Wie sind die Aussichten?

Der Pharmakonzern Pfizer verzeichnete am Freitag einen deutlichen Kursrückgang an der New Yorker Börse. Die Aktie des Unternehmens rutschte um…

Pfizer to pay $59.7 million over kickbacks for migraine drug By Reuters

Pfizer to pay $59.7 million over kickbacks for migraine drug…

Pfizer settles Biohaven kickback case with DOJ for $60M

…

Can This Beaten-Down Stock Bounce Back in 2025?

In 2022, pharmaceutical giant Pfizer (NYSE: PFE) became the first healthcare company to generate $100 billion in annual sales. But…

My Top 5 Stocks to Buy in Early 2025

Its the start of a new year, and that makes now the perfect time to load up on stocks that…

3 Dirt-Cheap Stocks to Buy in a Market Thats Priced for Perfection

How expensive is the stock market right now? The S&P 500 Shiller CAPE ratio is near its second-highest level ever.…

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

Youve probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the…

3 Subtle Investing Mistakes I Wont Repeat in 2025 And Beyond

Its normal to make more than a few flubs while investing, especially when youre new. At the same time, we…

Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,000 in Passive Income in 2025

What would it take to make over $3,000 this year with only barely lifting a finger? My answer is having…

The Smartest Dividend Stocks to Buy With $100 Right Now

A little money can go a long way. Thats especially the case when you invest in stocks that pay you…

3 High-Yield Dividend ETFs to Buy to Generate Passive Income

Exchange-traded funds (ETFs) are great options for those seeking to generate passive income. Many of these funds hold a portfolio…

Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks

Dividend yields can be like ladders: The higher you go, the scarier it gets. Many of us are more afraid…

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

The talks around drugs including Novo Nordisks Wegovy, GSKs Trelegy Ellipta, and Pfizers Xtandi will set Medicare prices that go…

Is Moderna a Bad-News Buy for 2025?

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in…

Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?

Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but the…

Antibody Drug Conjugates Market Outlook 2025-2035, with Forecasts for Payload Type, Linker Type, Target Antigen and Applications

Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market Report 2025-2035" has been added to…

Pfizer to further reduce stake in Haleon through share sale

Pfizer Inc (NYSE:PFE, ETR:PFE) plans to sell around 700 million shares of Haleon PLC (LSE:HLN, NYSE:HLN), representing a 7.7% stake,…

Pfizer to further reduce stake in Haleon through share sale

Pfizer Inc (NYSE:PFE, ETR:PFE) plans to sell around 700 million shares of Haleon PLC (LSE:HLN, NYSE:HLN), representing a 7.7% stake,…

Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund By Reuters

Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund…

Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports By Investing.com

Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports…

Pfizer intends to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner

Pfizer intends to sell about 700 million ordinary shares in Haleon , cutting its stake to about 7.3% in the…

Warum man die Pfizer-Aktie für einen Turnaround im Blick haben sollte!

Pfizer-CEO Albert Bourla betonte jüngst, er mache sich keine Sorgen über eine zweite Trump-Regierung oder den Aufstieg von Impfskeptikern wie…

Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline

Albert Bourla, Pfizer chairman and CEO, joins CNBCs Power Lunch to discuss the companys focus for 2025, whether bird flu…

Pfizer Inc. (PFE) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

…

Pfizer going all in on obesity drug development, CEO Bourla says

U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in…

Pfizer going all in on obesity drug development, CEO Bourla says By Reuters

Pfizer going all in on obesity drug development, CEO Bourla says…

3 High-Yield Dividend Stocks to Buy in 2025

High-yield dividend stocks may not appeal to some investors. However, if youre among those investors looking for income, stocks that…

Investing $5,000 Just Once in These 3 Ultra-High-Yielding Stocks Could Earn You $320 in Passive Income Every Year

Dividend stocks can be a great way to play the market. They typically provide reliable passive income and can offer…

9 Dividend ETFs to Buy With $200 and Hold Forever

Savvy investors know that dividends are powerful wealth builders -- and not, as many assume, sleepy, safe stocks for your…

Stocks to Watch Monday: Nvidia, Tesla, MicroStrategy, Pfizer

…

Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy

…

Pfizer must face lawsuit over diversity fellowship program, US court rules

A U.S. appeals court on Friday revived a lawsuit by a conservative group opposed to diversity initiatives in medicine that…

Pfizer must face lawsuit over diversity fellowship program, US court rules By Reuters

Pfizer must face lawsuit over diversity fellowship program, US court rules…

Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer

The global cancer immunotherapy market is primarily driven by the rising prevalence of cancer worldwide, leading to a growing demand…

dpa-AFX ProFeed